Premium Nahrungsergänzungsmittel | artgerecht

Statin-Associated Muscle Symptoms (SAMS) Explained

Statin-associated muscle symptoms (SAMS) are muscle-related side effects that can occur during statin therapy, ranging from mild muscle pain to rare severe muscle damage.

Regular tips about health Regular tips about health

Things worth knowing about "Statin-associated muscle symptoms"

Statin-associated muscle symptoms (SAMS) are muscle-related side effects that can occur during statin therapy, ranging from mild muscle pain to rare severe muscle damage.

What are statin-associated muscle symptoms?

Statin-associated muscle symptoms (SAMS) refer to a spectrum of muscle-related complaints that can develop during treatment with statins – cholesterol-lowering medications that are among the most widely prescribed drugs worldwide. While statins are generally well tolerated and provide significant cardiovascular benefits, a subset of patients experiences muscle-related side effects that can range from mild discomfort to rare but serious muscle damage.

Types and severity

SAMS are classified into several categories based on their severity:

Myalgia: Muscle pain or weakness without elevated muscle enzyme levels in the blood. This is the most common form.
Myositis: Muscle inflammation accompanied by elevated creatine kinase (CK) levels in the blood.
Myopathy: A general term for muscle disease, with or without elevated CK levels.
Rhabdomyolysis: A severe and rare form involving extensive muscle breakdown, markedly elevated CK levels, and the risk of acute kidney failure. This is a medical emergency.

Causes and risk factors

The exact mechanisms behind SAMS are not yet fully understood. Current hypotheses include:

Inhibition of coenzyme Q10 synthesis, which may impair energy production in muscle cells
Disruption of calcium homeostasis in muscle tissue
Genetic variants, particularly in the SLCO1B1 gene, which regulates statin transport into liver cells
Mitochondrial dysfunction

Several factors are known to increase the risk of SAMS:

Older age
Female sex
Kidney or liver disease
Hypothyroidism (underactive thyroid)
Concurrent use of interacting medications (e.g., fibrates, certain antibiotics, immunosuppressants)
High statin doses
Intense physical exercise

Symptoms

Typical symptoms of SAMS include:

Muscle pain (myalgia), most commonly in large muscle groups such as the thighs, buttocks, and shoulders
Muscle weakness, often noticed during daily activities such as climbing stairs
Muscle cramps
A general feeling of fatigue or heaviness in the muscles
In cases of rhabdomyolysis: dark (brown or cola-colored) urine, general malaise, and fever

Symptoms typically appear within weeks to months after starting statin therapy or following a dose increase.

Diagnosis

The diagnosis of SAMS is based on clinical assessment and laboratory testing:

Measurement of creatine kinase (CK) in the blood as a marker of muscle damage
Thyroid function tests (TSH) to rule out hypothyroidism
Kidney and liver function tests
Exclusion of other causes of muscle symptoms (e.g., inflammatory muscle diseases)
A statin discontinuation trial: if symptoms improve within 2–4 weeks of stopping the statin, a causal relationship is likely

The SAMS Clinical Index is a validated tool used to assess the probability of a causal link between statin use and muscle complaints.

Treatment and management

Management of SAMS depends on the severity of symptoms:

Mild to moderate symptoms

Temporary discontinuation of the statin to assess symptom resolution
Switching to a different statin (e.g., from simvastatin to rosuvastatin or pravastatin, which are generally better tolerated)
Dose reduction
Switching to an intermittent dosing schedule (e.g., three times per week)

Alternative treatment options

Ezetimibe: A non-statin cholesterol-lowering agent that can be used as an alternative or add-on therapy
PCSK9 inhibitors: Biologic agents for cholesterol reduction in patients who cannot tolerate statins
Bempedoic acid: A novel cholesterol-lowering drug with a different mechanism of action

Severe cases (rhabdomyolysis)

Immediate discontinuation of the statin
Hospitalization with aggressive intravenous fluid therapy to protect kidney function
Close monitoring of renal function

Important: Patients should never stop taking a statin without consulting their healthcare provider, as statins play a critical role in preventing heart attacks and strokes.

Prevention

To reduce the risk of SAMS, the following measures are recommended:

Regular monitoring of CK levels, especially at the start of therapy
Using the lowest effective statin dose
Reviewing potential drug interactions
Considering individual patient risk factors before initiating therapy

References

Stroes E.S. et al. - Statin-associated muscle symptoms: impact on statin therapy - European Heart Journal (2015), European Atherosclerosis Society Consensus Panel Statement.
Grundy S.M. et al. - 2018 AHA/ACC Guideline on the Management of Blood Cholesterol - Journal of the American College of Cardiology (2019).
Laufs U. et al. - Clinical Review on Muscle Side Effects of Statins - Circulation (2015).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category